| UniProt ID | BIEA_HUMAN | |
|---|---|---|
| UniProt AC | P53004 | |
| Protein Name | Biliverdin reductase A | |
| Gene Name | BLVRA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 296 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IX alpha, to bilirubin with the concomitant oxidation of a NADH or NADPH cofactor.. | |
| Protein Sequence | MNAEPERKFGVVVVGVGRAGSVRMRDLRNPHPSSAFLNLIGFVSRRELGSIDGVQQISLEDALSSQEVEVAYICSESSSHEDYIRQFLNAGKHVLVEYPMTLSLAAAQELWELAEQKGKVLHEEHVELLMEEFAFLKKEVVGKDLLKGSLLFTAGPLEEERFGFPAFSGISRLTWLVSLFGELSLVSATLEERKEDQYMKMTVCLETEKKSPLSWIEEKGPGLKRNRYLSFHFKSGSLENVPNVGVNKNIFLKDQNIFVQKLLGQFSEKELAAEKKRILHCLGLAEEIQKYCCSRK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MNAEPERK -------CCCCCHHC | 10.93 | - | |
| 21 | Phosphorylation | VGVGRAGSVRMRDLR EECCCCCCCHHHHCC | 12.93 | 22584576 | |
| 33 | Phosphorylation | DLRNPHPSSAFLNLI HCCCCCCCHHHHHHH | 31.12 | 22584576 | |
| 72 | Phosphorylation | SQEVEVAYICSESSS CCCEEEEEEECCCCC | 13.98 | 15870194 | |
| 83 | Phosphorylation | ESSSHEDYIRQFLNA CCCCCHHHHHHHHHC | 8.60 | 15870194 | |
| 130 | Sulfoxidation | EEHVELLMEEFAFLK HHHHHHHHHHHHHHH | 7.88 | 30846556 | |
| 143 | Ubiquitination | LKKEVVGKDLLKGSL HHHHHCCHHHHCCCE | 33.33 | - | |
| 143 | 2-Hydroxyisobutyrylation | LKKEVVGKDLLKGSL HHHHHCCHHHHCCCE | 33.33 | - | |
| 147 | Ubiquitination | VVGKDLLKGSLLFTA HCCHHHHCCCEEEEE | 54.47 | - | |
| 149 | Phosphorylation | GKDLLKGSLLFTAGP CHHHHCCCEEEEECC | 21.95 | 22065579 | |
| 174 | Phosphorylation | FSGISRLTWLVSLFG CCCHHHHHHHHHHHH | 18.68 | 22817900 | |
| 178 | Phosphorylation | SRLTWLVSLFGELSL HHHHHHHHHHHHHHH | 18.79 | 22817900 | |
| 198 | Phosphorylation | EERKEDQYMKMTVCL HHHHHHHCEEEEEEE | 15.83 | 15870194 | |
| 202 | Phosphorylation | EDQYMKMTVCLETEK HHHCEEEEEEEECCC | 11.53 | - | |
| 207 | Phosphorylation | KMTVCLETEKKSPLS EEEEEEECCCCCCCH | 39.91 | - | |
| 209 | 2-Hydroxyisobutyrylation | TVCLETEKKSPLSWI EEEEECCCCCCCHHH | 67.00 | - | |
| 210 | Ubiquitination | VCLETEKKSPLSWIE EEEECCCCCCCHHHH | 51.58 | - | |
| 211 | Phosphorylation | CLETEKKSPLSWIEE EEECCCCCCCHHHHH | 41.98 | 25159151 | |
| 219 | Ubiquitination | PLSWIEEKGPGLKRN CCHHHHHHCCCCCCC | 58.58 | 21890473 | |
| 219 | Acetylation | PLSWIEEKGPGLKRN CCHHHHHHCCCCCCC | 58.58 | 23954790 | |
| 228 | Phosphorylation | PGLKRNRYLSFHFKS CCCCCCCEEEEEECC | 15.39 | 15870194 | |
| 230 | Phosphorylation | LKRNRYLSFHFKSGS CCCCCEEEEEECCCC | 14.03 | 22617229 | |
| 234 | Methylation | RYLSFHFKSGSLENV CEEEEEECCCCCCCC | 45.39 | - | |
| 234 | Ubiquitination | RYLSFHFKSGSLENV CEEEEEECCCCCCCC | 45.39 | 21890473 | |
| 235 | Phosphorylation | YLSFHFKSGSLENVP EEEEEECCCCCCCCC | 32.44 | 30278072 | |
| 237 | Phosphorylation | SFHFKSGSLENVPNV EEEECCCCCCCCCCC | 39.33 | 30278072 | |
| 248 | Malonylation | VPNVGVNKNIFLKDQ CCCCCCCCCEEECCC | 49.35 | 26320211 | |
| 248 | Ubiquitination | VPNVGVNKNIFLKDQ CCCCCCCCCEEECCC | 49.35 | 21890473 | |
| 248 | Acetylation | VPNVGVNKNIFLKDQ CCCCCCCCCEEECCC | 49.35 | 19608861 | |
| 253 | Acetylation | VNKNIFLKDQNIFVQ CCCCEEECCCHHHHH | 46.66 | 19608861 | |
| 253 | Ubiquitination | VNKNIFLKDQNIFVQ CCCCEEECCCHHHHH | 46.66 | 21906983 | |
| 253 | 2-Hydroxyisobutyrylation | VNKNIFLKDQNIFVQ CCCCEEECCCHHHHH | 46.66 | - | |
| 261 | Acetylation | DQNIFVQKLLGQFSE CCHHHHHHHHHCCCH | 40.14 | 26051181 | |
| 261 | Ubiquitination | DQNIFVQKLLGQFSE CCHHHHHHHHHCCCH | 40.14 | 21890473 | |
| 269 | Acetylation | LLGQFSEKELAAEKK HHHCCCHHHHHHHHH | 57.75 | 21466224 | |
| 269 | Succinylation | LLGQFSEKELAAEKK HHHCCCHHHHHHHHH | 57.75 | 23954790 | |
| 269 | Ubiquitination | LLGQFSEKELAAEKK HHHCCCHHHHHHHHH | 57.75 | 21890473 | |
| 269 | 2-Hydroxyisobutyrylation | LLGQFSEKELAAEKK HHHCCCHHHHHHHHH | 57.75 | - | |
| 275 | 2-Hydroxyisobutyrylation | EKELAAEKKRILHCL HHHHHHHHHHHHHHH | 42.50 | - | |
| 281 | Glutathionylation | EKKRILHCLGLAEEI HHHHHHHHHHHHHHH | 2.64 | 22555962 | |
| 290 | Acetylation | GLAEEIQKYCCSRK- HHHHHHHHHHHCCC- | 46.01 | 25953088 | |
| 291 | Phosphorylation | LAEEIQKYCCSRK-- HHHHHHHHHHCCC-- | 5.15 | 15870194 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 21 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
| 33 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
| 72 | Y | Phosphorylation | Kinase | BLVRA | P53004 | GPS |
| 83 | Y | Phosphorylation | Kinase | BLVRA | P53004 | GPS |
| 149 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| 149 | S | Phosphorylation | Kinase | PKCZ | Q05513 | PSP |
| 198 | Y | Phosphorylation | Kinase | INSR | P06213 | PSP |
| 228 | Y | Phosphorylation | Kinase | INSR | P06213 | PSP |
| 230 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| 230 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
| 230 | S | Phosphorylation | Kinase | PKCZ | Q05513 | PSP |
| 230 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
| 237 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
| 291 | Y | Phosphorylation | Kinase | INSR | P06213 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BIEA_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BIEA_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LNX1_HUMAN | LNX1 | physical | 25416956 | |
| TLN1_HUMAN | TLN1 | physical | 26186194 | |
| TBX20_HUMAN | TBX20 | physical | 26186194 | |
| OSBL6_HUMAN | OSBPL6 | physical | 26186194 | |
| PCYOX_HUMAN | PCYOX1 | physical | 26186194 | |
| ARF5_HUMAN | ARF5 | physical | 26186194 | |
| RT4I1_HUMAN | RTN4IP1 | physical | 26186194 | |
| OCAD1_HUMAN | OCIAD1 | physical | 26186194 | |
| RRAGB_HUMAN | RRAGB | physical | 26186194 | |
| SNX5_HUMAN | SNX5 | physical | 26186194 | |
| DDHD2_HUMAN | DDHD2 | physical | 26186194 | |
| TBX20_HUMAN | TBX20 | physical | 28514442 | |
| DDHD2_HUMAN | DDHD2 | physical | 28514442 | |
| PCYOX_HUMAN | PCYOX1 | physical | 28514442 | |
| RT4I1_HUMAN | RTN4IP1 | physical | 28514442 | |
| RRAGB_HUMAN | RRAGB | physical | 28514442 | |
| OSBL6_HUMAN | OSBPL6 | physical | 28514442 | |
| TLN1_HUMAN | TLN1 | physical | 28514442 | |
| DNSL2_HUMAN | DNASE1L2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 614156 | Hyperbiliverdinemia (HBLVD) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-237, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-248 AND LYS-253, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-174 AND SER-178, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-237, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230, AND MASSSPECTROMETRY. | |